Ana Duarte, MD
Dermatology · Miami, FLNPI 1861462806
Payments from drug & device makers
Across 495 payments — averaging $1007.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$181K
- UCB SA$82K
- Incyte Corporation$64K
- Regeneron Healthcare Solutions, Inc.$56K
- Novartis$53K
- Sanofi$24K
- plus $38K from 29 others
Across 2 payments — averaging $4612.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$9K
What the payments were for
- Consulting fees$9,0208%
- Speaking & faculty fees$84,84279%
- Travel & lodging$2,3932%
- Food & beverage$10,44510%
- Education$1940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 155 | $181,144 |
| UCB SA | 6 | $82,421 |
| Incyte Corporation | 22 | $64,263 |
| Regeneron Healthcare Solutions, Inc. | 69 | $56,425 |
| Novartis | 4 | $52,965 |
| Sanofi | 48 | $23,968 |
| Sanofi US Services Inc. | 2 | $12,262 |
| Galderma Laboratories, L.p. | 22 | $9,942 |
| Aclaris Therapeutics, Inc. | 5 | $9,773 |
| LEO Pharma Inc. | 6 | $1,783 |
| AbbVie | 24 | $824 |
| Sun Pharmaceutical Industries Inc. | 42 | $751 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $413 |
| Johnson & Johnson | 16 | $401 |
| Lilly USA, LLC | 8 | $307 |
| Pierre Fabre Pharmaceuticals, Inc. | 9 | $175 |
| Dermavant Sciences, Inc. | 10 | $171 |
| Journey Medical Corporation | 5 | $165 |
| Krystal Biotech Inc | 1 | $125 |
| Dermira, Inc. | 4 | $72 |
| Organon | 3 | $70 |
| Arcutis Biotherapeutics, Inc. | 3 | $61 |
| Botanix SB Inc | 2 | $47 |
| Strata Skin Sciences, Inc. | 4 | $43 |
| Nobelpharma America, LLC | 2 | $35 |
| EPI Health, LLC | 2 | $33 |
| AstraZeneca | 1 | $30 |
| Boehringer Ingelheim | 1 | $29 |
| Cipher Pharmaceuticals US LLC | 1 | $28 |
| LNHC, Inc | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Amgen | 1 | $18 |
| Almirall LLC | 1 | $18 |
| Biofrontera Inc. | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$498,825 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $299,719 |
| Clobetasol Propionate | 24 | $2,376 |
| Fluorouracil | 31 | $2,352 |
| Ketoconazole | 154 | $1,967 |
| Metronidazole | 18 | $1,262 |
| Mometasone Furoate | 57 | $831 |
| Clindamycin Phosphate | 22 | $816 |
| Triamcinolone Acetonide | 66 | $720 |
| Ciclopirox | 35 | $602 |
| Nystatin | 26 | $285 |
| Fluticasone Propionate | 13 | $219 |
| Hydrocortisone | 12 | $184 |
| Mupirocin | 29 | $137 |
| Doxycycline Hyclate | 13 | $109 |
| Ammonium Lactate | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Miami
- Hector Wiltz JrMiami$6.4M
- Francisco KerdelMiami$5.1M
- Jill WaibelMiami$4.3M
- Gil YosipovitchMiami$3.7M
- Mercedes GonzalezMiami$3.6M
- Giovanna CioccaMiami$3.2M
- David RodriguezMiami$3M
- Hadar Lev-TovMiami$2.5M
- Leslie BaumannMiami$2.3M
- Mojgan HosseinipourMiami$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.